Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
AIDS (London, England)|July 30, 2005
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccineLucy Dorrell, Hongbing Yang, Astrid Kn Iversen, et al.European Journal of Immunology|October 3, 2006
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responsesBeatrice O Ondondo, Hongbing Yang, Tao Dong, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2007
Broad TCR usage in functional HIV-1-specific CD8+ T cell expansions driven by vaccination during highly active antiretroviral therapyHongbing Yang, Tao Dong, Emma Turnbull, et al.Journal of Virology|April 28, 2006
Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccineLucy Dorrell, Hongbing Yang, Beatrice Ondondo, et al.Vaccine|September 24, 2005
Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersInese Cebere, Lucy Dorrell, Helen McShane, et al.Clinical Therapeutics|July 18, 2003
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulationsJane P Barrett, Katerina A Vardulaki, Christopher Conlon, et al.Cancer Immunology Research|June 20, 2019
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte ResponsesMegat Abd Hamid, Ruo-Zheng Wang, Xuan Yao, et al.The Lancet. Infectious Diseases|January 19, 2019
Clinical utility of existing and second-generation interferon-γ release assays for diagnostic evaluation of tuberculosis: an observational cohort studyHilary S Whitworth, Amarjit Badhan, Aime A Boakye, et al.The Journal of General Virology|March 25, 2004
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humansMatilu Mwau, Inese Cebere, Julian Sutton, et al.Plos Biology|February 18, 2004
Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infectionLaura Papagno, Celsa A Spina, Arnaud Marchant, et al.Pageof 3